The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation

被引:33
作者
Witt, CS [1 ]
Christiansen, FT
机构
[1] Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA, Australia
[2] Univ Western Australia, Sch Surg & Pathol, Perth, WA, Australia
[3] Western Australia Inst Med Res, Nedlands, WA, Australia
关键词
bone marrow transplantation; KIR; NK cells;
D O I
10.1111/j.1423-0410.2005.00712.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The discovery that killer cell immunoglobulin-like receptors (KIR) interact with genetically polymorphic epitopes on class I human leucocyte antigen (HLA) molecules and that the KIR receptor repertoire itself is genetically variable has led to investigation of the relevance of the KIR system to stem cell transplantation. A number of retrospective studies of transplant outcome have now demonstrated either beneficial or deleterious effects of mismatching for class I natural killer (NK) epitopes. A smaller number of studies have shown effects of the donor and/or patient KIR repertoire on outcome, irrespective of the patient and donor HLA type. The most parsimonious interpretation of the data, which are often conflicting, is that the effect of NK epitope matching is very much dependent on transplant protocols, with the extent of donor T-cell depletion possibly being the most important variable. A clearer picture of the role of matching for NK epitopes and the KIR-receptor repertoire of the donor is needed.
引用
收藏
页码:10 / 20
页数:11
相关论文
共 37 条
[1]   Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation [J].
Asai, O ;
Longo, DL ;
Tian, ZG ;
Hornung, RL ;
Taub, DD ;
Ruscetti, FW ;
Murphy, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09) :1835-1842
[2]   Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias [J].
Beelen, DW ;
Ottinger, HD ;
Ferencik, S ;
Elmaagacli, AH ;
Peceny, R ;
Trenschel, R ;
Grosse-Wilde, H .
BLOOD, 2005, 105 (06) :2594-2600
[3]   The beneficial role of inhibitory KIR genes of HLA class INK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD [J].
Bishara, A ;
De Santis, D ;
Witt, CC ;
Brautbar, C ;
Christiansen, FT ;
Or, R ;
Nagler, A ;
Slavin, S .
TISSUE ANTIGENS, 2004, 63 (03) :204-211
[4]   Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors [J].
Bornhäuser, M ;
Schwerdtfeger, R ;
Martin, H ;
Frank, KH ;
Theuser, C ;
Ehninger, G .
BLOOD, 2004, 103 (07) :2860-2861
[5]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[6]   The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia [J].
Cook, MA ;
Milligan, DW ;
Fegan, CD ;
Darbyshire, PJ ;
Mahendra, P ;
Craddock, CF ;
Moss, PAH ;
Briggs, DC .
BLOOD, 2004, 103 (04) :1521-1526
[7]   Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants [J].
Davies, SM ;
Ruggieri, L ;
DeFor, T ;
Wagner, JE ;
Weisdorf, DJ ;
Miller, JS ;
Velardi, A ;
Blazar, BR .
BLOOD, 2002, 100 (10) :3825-3827
[8]   Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants [J].
De Santis, D ;
Bishara, A ;
Witt, CS ;
Nagler, A ;
Brautbar, C ;
Slavin, S ;
Christiansen, FT .
TISSUE ANTIGENS, 2005, 65 (06) :519-528
[9]   EVIDENCE THAT LARGE GRANULAR LYMPHOCYTES OF DONOR ORIGIN MEDIATE ACUTE GRAFT-VERSUS-HOST DISEASE [J].
FERRARA, JLM ;
GUILLEN, FJ ;
VANDIJKEN, PJ ;
MARION, A ;
MURPHY, GF ;
BURAKOFF, SJ .
TRANSPLANTATION, 1989, 47 (01) :50-54
[10]   Relevance of KIR gene polymorphisms in bone marrow transplantation outcome [J].
Gagne, K ;
Brizard, G ;
Gueglio, B ;
Milpied, N ;
Herry, P ;
Bonneville, F ;
Chéneau, ML ;
Schleinitz, N ;
Cesbron, A ;
Folléa, G ;
Harrousseau, JL ;
Bignon, JD .
HUMAN IMMUNOLOGY, 2002, 63 (04) :271-280